Occupational Therapists in Vermont - Medicare Status, Address, Contact

312 Occupational Therapists found. Showing 41 - 60

Live Full Therapies Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 71 Mountain St, Bristol, VT 05443 Phone: 802-349-6792

Po Jung Pan Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-2450

Mary Hanson, OT/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 43 Starr Farm Rd, Burlington, VT 05408 Phone: 802-419-2421

Mckenzie Jo Hartman-mattson, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 218-235-9355

Kylie Stevenson-lyon, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-1000

Sara Degaetano, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Sheperdson 2, Burlington, VT 05401 Phone: 802-847-2450

Alyssa Morgan Smith, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000

Clara Shealy, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000

Genevieve St Onge, OTR-CLT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Pearl St, Burlington, VT 05401 Phone: 802-658-4200

Ms. Rebecca T Grimm, MS Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 70 Drew St, Burlington, VT 05401 Phone: 802-658-1900

Alan Dunn, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-6025

Macie S Fletcher, OTD Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-2450

Tess Rielley, ORT/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 98 Starr Farm Rd, Burlington, VT 05408 Phone: 802-658-6713

Ellen Snyder, MOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Pearl St, Burlington, VT 05401 Phone: 802-658-4200

Andrea Erena, MSOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Pearl St, Burlington, VT 05401 Phone: 802-658-4200

Mr. Steven Charles Eyler, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-6921

Workability Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 208 Flynn Ave Ste 3e, Burlington, VT 05401 Phone: 802-383-8116

Barbara B Blokland, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-2450    Fax: 802-847-3756

Marissa Lee Stevens Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 98 Starr Farm Rd, Burlington, VT 05408 Phone: 802-658-6717

Whitney Marie Shifflett, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Pearl St, Burlington, VT 05401 Phone: 802-658-4200

News Archive

World class scientist presents fourth Environmental Microbiology Lecture

World class scientist Professor Willem M. de Vos will explain next Monday how the microbes that are closest to our hearts - gut microbes - could underpin a new way of thinking about human biology. As well as looking at our own genes, we can now include those of our microbes in studies of human health and disease. This is a significant shift in the way we approach human biology.

Nasdaq Stock Market issues delisting notice to Metabasis Therapeutics

Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that on September 4, 2009 it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market (the "Staff") notifying the Company that it did not comply with the minimum $2,500,000 stockholders' equity requirement for continued listing, set forth in Listing Rule 5550(b), prior to the expiration of the extension for such compliance granted by the Staff on June 25, 2009, and that as a result, unless the Company requests an appeal of the Staff's delisting determination, trading of the Company's common stock on the Nasdaq Capital Market will be suspended at the opening of business on September 15, 2009.

Chelsea presents Northera study data at International Congress on Parkinson's Disease and Movement Disorders

Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.

Preliminary study suggests nitric oxide may be a potential treatment for COVID-19 respiratory failure

New research led by Devang K. Sanghavi of the Mayo Clinic in Florida, USA, suggests pre-intubation use of nitric oxide for patients with COVID-19–related hypoxemic respiratory may help reduce patients' mortality. Their findings show that inhaling nitric oxide in this patient population could reduce the need for future intubation and other invasive mechanical ventilation.

Emergent BioSolutions acquires 55,000 square foot manufacturing facility from MdBio Foundation

Emergent BioSolutions Inc. announced today that it has completed the acquisition of a 55,000 square foot manufacturing facility from MdBio Foundation and the land on which the facility stands from the City of Baltimore for a total purchase price of $8.2 million. The facility, located within the City of Baltimore, Maryland, previously operated as a Food and Drug Administration (FDA) licensed facility used by an experienced contract manufacturing organization (CMO) to produce a number of FDA approved products.

Read more Medical News

› Verified 4 days ago

• 1
• 2
• 3(current)
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• »